STERIS plc (NYSE:STE) Plans Quarterly Dividend of $0.63

STERIS plc (NYSE:STE) declared a quarterly dividend on Tuesday, May 5th. Stockholders of record on Monday, June 8th will be paid a dividend of 0.63 per share by the medical equipment provider on Friday, June 26th. This represents a c) annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Monday, June 8th.

STERIS has raised its dividend payment by an average of 0.1%annually over the last three years and has raised its dividend annually for the last 20 consecutive years. STERIS has a dividend payout ratio of 22.9% indicating that its dividend is sufficiently covered by earnings. Analysts expect STERIS to earn $11.04 per share next year, which means the company should continue to be able to cover its $2.52 annual dividend with an expected future payout ratio of 22.8%.

STERIS Stock Up 1.1%

NYSE:STE opened at $215.26 on Wednesday. The firm has a market capitalization of $21.11 billion, a P/E ratio of 30.10 and a beta of 0.95. The company’s fifty day moving average price is $225.61 and its 200-day moving average price is $244.63. STERIS has a 1-year low of $209.61 and a 1-year high of $269.44. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.48 and a quick ratio of 1.75.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, hitting the consensus estimate of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.STERIS’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.32 EPS. As a group, equities research analysts anticipate that STERIS will post 10.22 EPS for the current year.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.